Maïlys Ragot, Pauline Reynaud-Orhon, Alban Revy, Marie Batisse-Lignier, Valentin Brusseau, Antony Kelly, Hosameldin Otman, Florent Cachin, Marion Chanchou, Sophie Levesque, Marion Tempier
{"title":"Development of an automated radiosynthesis for [68Ga]Ga-NODAGA[40Lys]-Exendin-4 in sodium acetate buffer","authors":"Maïlys Ragot, Pauline Reynaud-Orhon, Alban Revy, Marie Batisse-Lignier, Valentin Brusseau, Antony Kelly, Hosameldin Otman, Florent Cachin, Marion Chanchou, Sophie Levesque, Marion Tempier","doi":"10.1186/s41181-026-00452-0","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>[<sup>68</sup>Ga]Ga-NODAGA[40Lys]-Exendin-4 (<sup>68</sup>Ga-Ex-4) is a new PET radiopharmaceutical targeting GLP-1-R that showed great specificity and sensitivity in the topographic diagnosis of benign insulinoma. We herein report the development of a new method for <sup>68</sup>Ga-Ex-4 radiolabeling in sodium acetate buffer, automated on the miniAllinOne synthesizer.</p><h3>Results</h3><p>Key parameters were reaction volume, due to low amount of peptide, and pH. At a reaction volume of 2.65 mL and pH 2.9, the reaction yielded 80% of <sup>68</sup>Ga-Ex-4. The use of polysorbate and cooling of the solution allows to decrease the adsorption on the reaction vial (from 29 to 2% of total activity remaining on the vial). <sup>68</sup>Ga-Ex-4 is purified on a HLB cartridge. Final product was obtained within 40 min, with a mean radiochemical purity of 97% and a radiochemical yield of 67%.</p><h3>Conclusions</h3><p>We have successfully developed a new radiolabeling method for [<sup>68</sup>Ga]Ga-NODAGA-[40Lys]Exendin-4, automated on a miniAllinOne synthesizer and using sodium acetate buffer, suitable for clinical application.</p></div>","PeriodicalId":534,"journal":{"name":"EJNMMI Radiopharmacy and Chemistry","volume":"11 1","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13437812/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EJNMMI Radiopharmacy and Chemistry","FirstCategoryId":"1085","ListUrlMain":"https://link.springer.com/article/10.1186/s41181-026-00452-0","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/8/5 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CHEMISTRY, INORGANIC & NUCLEAR","Score":null,"Total":0}
引用次数: 0
Abstract
Background
[68Ga]Ga-NODAGA[40Lys]-Exendin-4 (68Ga-Ex-4) is a new PET radiopharmaceutical targeting GLP-1-R that showed great specificity and sensitivity in the topographic diagnosis of benign insulinoma. We herein report the development of a new method for 68Ga-Ex-4 radiolabeling in sodium acetate buffer, automated on the miniAllinOne synthesizer.
Results
Key parameters were reaction volume, due to low amount of peptide, and pH. At a reaction volume of 2.65 mL and pH 2.9, the reaction yielded 80% of 68Ga-Ex-4. The use of polysorbate and cooling of the solution allows to decrease the adsorption on the reaction vial (from 29 to 2% of total activity remaining on the vial). 68Ga-Ex-4 is purified on a HLB cartridge. Final product was obtained within 40 min, with a mean radiochemical purity of 97% and a radiochemical yield of 67%.
Conclusions
We have successfully developed a new radiolabeling method for [68Ga]Ga-NODAGA-[40Lys]Exendin-4, automated on a miniAllinOne synthesizer and using sodium acetate buffer, suitable for clinical application.